Group One Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
1,399,500
+1,287,970
+1,155% +$5.86M ﹤0.01% 2704
2025
Q4
$622K Buy
111,530
+100,370
+899% +$1.12M ﹤0.01% 3292
2025
Q3
$82.3K Sell
11,160
-1,345
-11% -$11.4K ﹤0.01% 5527
2025
Q2
$95.3K Sell
12,505
-12,220
-49% -$190K ﹤0.01% 5010
2025
Q1
$472K Sell
24,725
-965
-4% -$30.3K ﹤0.01% 3158
2024
Q4
$930K Buy
25,690
+23,610
+1,135% +$657K ﹤0.01% 2639
2024
Q3
$59.9K Sell
2,080
-1,185
-36% -$26.3K ﹤0.01% 4527
2024
Q2
$83.6K Sell
3,265
-4,310
-57% -$196K ﹤0.01% 4104
2024
Q1
$573K Sell
7,575
-1,310
-15% -$104K ﹤0.01% 2601
2023
Q4
$915K Sell
8,885
-1,675
-16% -$150K ﹤0.01% 2534
2023
Q3
$1.03M Sell
10,560
-37,400
-78% -$3.49M ﹤0.01% 2236
2023
Q2
$5.62M Buy
47,960
+43,630
+1,008% +$5.53M 0.02% 870
2023
Q1
$363K Sell
4,330
-945
-18% -$82.5K ﹤0.01% 3071
2022
Q4
$448K Buy
5,275
+870
+20% +$66.4K ﹤0.01% 3145
2022
Q3
$140K Buy
4,405
+4,070
+1,215% +$112K ﹤0.01% 4469
2022
Q2
$7K Buy
+335
New +$11.7K ﹤0.01% 6953

Other funds holding RVPH

Group One Trading's RVPH Position: Q1 2026 in Review

Group One Trading reduced its REVIVA PHARMA HLDGS INC (RVPH) stake by 0.29% in Q1 2026, selling an estimated $41 and leaving 3,109 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #7014.

Group One Trading first reported a position in RVPH in Q3 2023 and has held it in 5 quarters since. The position peaked at $631K in Q3 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Group One Trading held 3,109 shares of REVIVA PHARMA HLDGS INC worth $2.27K as of Q1 2026.
  • Group One Trading sold 9 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $41.
  • REVIVA PHARMA HLDGS INC made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7014 holding.
  • Group One Trading first reported a position in REVIVA PHARMA HLDGS INC in Q3 2023 and has held it in 5 quarters since.
  • Group One Trading's REVIVA PHARMA HLDGS INC position peaked at $631K in Q3 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.